Reference,Reference: DOI,Assay,Section,Pre-vaccine Infection,Vaccine,# Shots,Months,Host,Control,Control: NT50 Cmp,Control: NT50 GeoMean,Control: NT50 GSD,Variant,Variant: Pos,Variant: Mutations,# Results,Potency: NT50 Cmp,Potency: NT50 GeoMean,Potency: NT50 GSD,Fold Reduction: Cmp,Fold Reduction: Median
Jacobsen22,10.1038/s41598-022-22552-y,Pseudovirus (VSV),41598_2022_22552_MOESM2_ESM.xlsx,None,AZD1222 + mRNA-1273,2,2-6m,Human,Wild Type (B.1),=,61.9,1.0,Omicron/BA.2.12.1,19,T19I + L24S + Δ25-27 + G142D + V213G + G339D + S371F + S373P + S375F + T376A + D405N + R408S + K417N + N440K + L452Q + S477N + T478K + E484A + Q493R + Q498R + N501Y + Y505H + H655Y + N679K + P681H + S704L + N764K + D796Y + Q954H + N969K,1,<,1.0,1.0,>,61.9